T9L Science Foundry. Weather, Skill

About us

T9L is a Science Foundry that works alongside scientists, researchers and institutions to transform high-potential research into commercially viable deep-tech companies.

Our model brings together leading scientific minds, experienced company builders and long-term capital through four core capabilities: Find, Validate, Build and Capitalise. We identify promising research, validate its technical readiness and commercial potential, productise the underlying IP, build the company and prepare it for specialist capital, strategic partnerships and scale.

80+PortfolioStartups
$2Bn+Past PortfolioValuation
$450MnRaised byVentures
20+Exits
60%SuccessRate

What T9LBuilds Around It

Productization
Translate research into a clearly defined product by identifying the core use case, target user, technical requirements and path from scientific capability to a deployable solution.
Commercialization Strategy
Validate critical user pain points, assess willingness to adopt and pay, and determine where the technology creates enough value to support a viable business model.
Venture Structuring & Operations
Build the company around the science, including entity structure, operating model, governance, processes, financial planning and the systems required to run and scale the venture.
Team Building
Identify the capabilities the venture needs beyond the founding scientific team, then attract and build leadership, technical, commercial and operating talent around the opportunity.
Brand & Market Positioning
Shape how the company is understood by customers, partners, talent and investors through clear positioning, messaging, brand identity and category definition.
Fundraising & Capital Strategy
Prepare the venture for specialist capital by defining the funding roadmap, investor narrative, milestones, capital requirements and the right mix of investors and strategic partners.
Go-to-Market & Distribution
Design the path from product to customer by identifying priority segments, channels, partnerships, pilots and commercial entry points that can drive early adoption and scale.
Policy & Regulatory Navigation
Map the regulatory, policy and institutional environment around the venture, identify approvals and compliance requirements, and build a pathway that supports commercial deployment.
Legal & IP Protection
Structure ownership of intellectual property, protect defensible assets, establish the right legal frameworks and ensure commercial rights are secured as the venture is built.

Our Portfolio

Where ScienceFinds Its Next Chapter

All companies

HealthTech

Aayul

Aayul is building a precision-oncology platform using CAR-T technology to reprogramme patients’ immune cells to fight blood cancers and solid tumours. Through its AIIMS Delhi partnership and India-based manufacturing, it aims to make advanced therapies more effective, accessible and commercially scalable while developing proprietary IP.

T9L is co-building the business, shaping its IP, clinical and regulatory strategy, infrastructure, partnerships, funding and commercial model to take therapies from the laboratory to patients and global markets.

aayul.com